{"id":1737,"date":"2018-03-04T18:32:55","date_gmt":"2018-03-05T00:32:55","guid":{"rendered":"https:\/\/restruct-lgmd-2021.pantheonsite.io\/?p=1737"},"modified":"2018-03-04T18:32:55","modified_gmt":"2018-03-05T00:32:55","slug":"1737","status":"publish","type":"post","link":"https:\/\/www.lgmd-info.org\/tr\/researcher-interview\/2018\/03\/04\/1737\/","title":{"rendered":"LGMD ARA\u015eTIRMACISI: Louise Rodino-Klapac, Ph.D"},"content":{"rendered":"<h2><span style=\"color: #008000;\"><strong>LGMD \"Ara\u015ft\u0131rma \u00dczerine Spotlight R\u00f6portaj\u0131\" <\/strong><\/span><\/h2>\n<p><strong>LGMD Ara\u015ft\u0131rmac\u0131s\u0131:<\/strong> Louise Rodino-Klapac, Ph.D<a href=\"https:\/\/www.lgmd-info.org\/wp-content\/uploads\/2018\/03\/Louise-Rodino-Klapac.png\"><img decoding=\"async\" class=\"lazyload size-medium wp-image-1735 alignright\" src=\"data:image\/svg+xml,%3Csvg%20xmlns%3D%27http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%27%20width%3D%27300%27%20height%3D%27225%27%20viewBox%3D%270%200%20300%20225%27%3E%3Crect%20width%3D%27300%27%20height%3D%27225%27%20fill-opacity%3D%220%22%2F%3E%3C%2Fsvg%3E\" data-orig-src=\"https:\/\/www.lgmd-info.org\/wp-content\/uploads\/2018\/03\/Louise-Rodino-Klapac-300x225.png\" alt=\"\" width=\"300\" height=\"225\" \/><\/a><\/p>\n<p><strong>Ba\u011fl\u0131l\u0131k:\u00a0 <\/strong>Nationwide Children's Hospital ve Myonexus Therapeutics, Inc.<\/p>\n<p><strong>Rol veya Pozisyon<\/strong>: Do\u00e7ent (NCH) ve Ba\u015f Bilim Sorumlusu (Myonexus)<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p><strong>\u015eu anki pozisyonunuza gelmek i\u00e7in hangi e\u011fitim ve \u00f6\u011fretimi ald\u0131n\u0131z?<\/strong><\/p>\n<p>Molek\u00fcler genetik alan\u0131nda n\u00f6rom\u00fcsk\u00fcler geli\u015fim \u00fczerine doktora yapt\u0131m.  Daha sonra Jerry Mendell'in ak\u0131l hocal\u0131\u011f\u0131 ile \u00fclke \u00e7ap\u0131nda bir \u00e7ocuk hastanesinde gen terapisi alan\u0131nda doktora sonras\u0131 burs yapt\u0131m.<\/p>\n<p><strong>Sizi ara\u015ft\u0131rma alan\u0131nda kariyer yapmaya ve \u00f6zellikle kas distrofisi \u00fczerine \u00e7al\u0131\u015fmaya y\u00f6nlendiren neydi?<\/strong><\/p>\n<p>Gen\u00e7 ya\u015flardan itibaren ara\u015ft\u0131rmac\u0131 olmak istedi\u011fimi biliyordum.  Genetik ve kusurlu genlerin nas\u0131l hastal\u0131\u011fa neden olabilece\u011fi beni b\u00fcy\u00fcl\u00fcyordu.  Lisans\u00fcst\u00fc \u00e7al\u0131\u015fmalar\u0131m i\u00e7in n\u00f6rom\u00fcsk\u00fcler geli\u015fim \u00fczerine \u00e7al\u0131\u015ft\u0131m ve kas hastal\u0131klar\u0131na y\u00f6nelik tedaviler geli\u015ftirmek i\u00e7in bu bilgilerden yararlanmak istiyordum.  Neyse ki, kas distrofisi ara\u015ft\u0131rmalar\u0131 Nationwide Children's'da bana hedeflerimi ger\u00e7ekle\u015ftirme f\u0131rsat\u0131 veren bir vurgu alan\u0131.<\/p>\n<p><strong>Hangi konular \u00fczerinde \u00e7al\u0131\u015f\u0131yorsunuz?<\/strong><\/p>\n<p>Limb Girdle ve Duchenne Musk\u00fcler Distrofi i\u00e7in gen terapisi tedavileri geli\u015ftiriyorum ve bu tedavileri klinik deneylere d\u00f6n\u00fc\u015ft\u00fcr\u00fcyorum.  Laboratuvar\u0131m ayr\u0131ca Limb Girdle Musk\u00fcler Distrofilerinin hastal\u0131k mekanizmalar\u0131n\u0131 da incelemektedir.<\/p>\n<p><strong>\u00c7al\u0131\u015fman\u0131z hastalara nas\u0131l yard\u0131mc\u0131 olacak? Do\u011fas\u0131 gere\u011fi daha bilimsel mi yoksa LGMD'ler veya genel olarak MD'ler i\u00e7in bir tedavi olabilir mi?<\/strong><\/p>\n<p>\u00c7al\u0131\u015fmalar\u0131m\u0131z hastalar i\u00e7in do\u011frudan uygulanabilir niteliktedir.  LGMD'nin \u00e7e\u015fitli formlar\u0131 (2B, 2D, 2E) i\u00e7in devam eden ve yakla\u015fan klinik \u00e7al\u0131\u015fmalar\u0131m\u0131z var ve di\u011fer alt tipler i\u00e7in klinik \u00e7al\u0131\u015fmalar planl\u0131yoruz.  Gen replasman\u0131n\u0131n MD'ler i\u00e7in anlaml\u0131 bir tedavi olaca\u011f\u0131 konusunda \u00e7ok iyimseriz.<\/p>\n<p><strong>Hastalar\u0131n ve LGMD ile ilgilenen di\u011fer ki\u015filerin ara\u015ft\u0131rma hakk\u0131nda (kendi projeleriniz ve genel olarak alan hakk\u0131nda) ne bilmelerini istersiniz?<\/strong><\/p>\n<p>LGMD ara\u015ft\u0131rmalar\u0131 i\u00e7in \u00e7ok heyecan verici bir d\u00f6nem.  Genetik testlerdeki geli\u015fmeler ve di\u011fer n\u00f6rom\u00fcsk\u00fcler hastal\u0131klarda gen terapisindeki ba\u015far\u0131lar, LGMD i\u00e7in ara\u015ft\u0131rma ve klinik denemeleri h\u0131zland\u0131rd\u0131.  Bir LGMD formunu incelerken \u00f6\u011frendiklerimizi h\u0131zla di\u011ferine uygulayabiliriz.<\/p>\n<p><strong>Bu alanda \u00e7al\u0131\u015fmaya devam etmek i\u00e7in size ilham veren nedir? <\/strong><\/p>\n<p>Hastalar benim en b\u00fcy\u00fck ilham kayna\u011f\u0131m. Tedavileri klini\u011fe ta\u015f\u0131mak i\u00e7in yapt\u0131\u011f\u0131m\u0131z t\u00fcm s\u0131k\u0131 \u00e7al\u0131\u015fmalar\u0131n umar\u0131m hastalara \u00e7ok anlaml\u0131 bir \u015fekilde fayda sa\u011flayaca\u011f\u0131n\u0131 bilmek \u00e7ok \u00f6d\u00fcllendirici!<\/p>\n<p><strong>Hastalar sizi nas\u0131l te\u015fvik edebilir ve \u00e7al\u0131\u015fmalar\u0131n\u0131za nas\u0131l yard\u0131mc\u0131 olabilir?<\/strong><\/p>\n<p>Hastalardan hikayeler duymak (hem umut hem de zorluk hikayeleri) son derece faydal\u0131d\u0131r.  Ara\u015ft\u0131rmac\u0131lar olarak, m\u00fcmk\u00fcnse tedavileri uyarlamak i\u00e7in her bir hastal\u0131\u011fa \u00f6zg\u00fc zorluklar\u0131 bilmemize yard\u0131mc\u0131 oluyor.  Dahas\u0131, arkan\u0131zda b\u00fcy\u00fck bir destek\u00e7i ekibi oldu\u011funu bilerek s\u0131k\u0131 \u00e7al\u0131\u015fmaya devam etmek i\u00e7in s\u00fcrekli bir motivasyon kayna\u011f\u0131d\u0131r!<\/p>","protected":false},"excerpt":{"rendered":"<p>LGMD &#8220;Spotlight Interview on Research\u201d LGMD Researcher: Louise Rodino-Klapac, Ph.D [&hellip;]<\/p>","protected":false},"author":1,"featured_media":1735,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[91,92],"tags":[],"class_list":["post-1737","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-researcher-interview","category-researcher"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>LGMD RESEARCHER: Louise Rodino-Klapac, Ph.D - LGMD Awareness Foundation<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"http:\/\/www.lgmd-info.org\/tr\/researcher-interview\/2018\/03\/04\/1737\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"LGMD RESEARCHER: Louise Rodino-Klapac, Ph.D - LGMD Awareness Foundation\" \/>\n<meta property=\"og:description\" content=\"LGMD &#8220;Spotlight Interview on Research\u201d LGMD Researcher: Louise Rodino-Klapac, Ph.D [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"http:\/\/www.lgmd-info.org\/tr\/researcher-interview\/2018\/03\/04\/1737\/\" \/>\n<meta property=\"og:site_name\" content=\"LGMD Awareness Foundation\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/LGMDawareness\/\" \/>\n<meta property=\"article:published_time\" content=\"2018-03-05T00:32:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.lgmd-info.org\/wp-content\/uploads\/2021\/06\/LGMD-Logo_1200X630.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"dooley\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@LgmdAwareness\" \/>\n<meta name=\"twitter:site\" content=\"@LgmdAwareness\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"dooley\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"http:\/\/www.lgmd-info.org\/researcher-interview\/2018\/03\/04\/1737\/#article\",\"isPartOf\":{\"@id\":\"http:\/\/www.lgmd-info.org\/researcher-interview\/2018\/03\/04\/1737\/\"},\"author\":{\"name\":\"dooley\",\"@id\":\"https:\/\/www.lgmd-info.org\/de\/#\/schema\/person\/007755074875959ad5503c1c969678c7\"},\"headline\":\"LGMD RESEARCHER: Louise Rodino-Klapac, Ph.D\",\"datePublished\":\"2018-03-05T00:32:55+00:00\",\"dateModified\":\"2018-03-05T00:32:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"http:\/\/www.lgmd-info.org\/researcher-interview\/2018\/03\/04\/1737\/\"},\"wordCount\":444,\"publisher\":{\"@id\":\"https:\/\/www.lgmd-info.org\/de\/#organization\"},\"image\":{\"@id\":\"http:\/\/www.lgmd-info.org\/researcher-interview\/2018\/03\/04\/1737\/#primaryimage\"},\"thumbnailUrl\":\"\",\"articleSection\":[\"LGMD Researcher - Interviews\",\"RESEARCHER\"],\"inLanguage\":\"tr-TR\"},{\"@type\":\"WebPage\",\"@id\":\"http:\/\/www.lgmd-info.org\/researcher-interview\/2018\/03\/04\/1737\/\",\"url\":\"http:\/\/www.lgmd-info.org\/researcher-interview\/2018\/03\/04\/1737\/\",\"name\":\"LGMD RESEARCHER: Louise Rodino-Klapac, Ph.D - LGMD Awareness Foundation\",\"isPartOf\":{\"@id\":\"https:\/\/www.lgmd-info.org\/de\/#website\"},\"primaryImageOfPage\":{\"@id\":\"http:\/\/www.lgmd-info.org\/researcher-interview\/2018\/03\/04\/1737\/#primaryimage\"},\"image\":{\"@id\":\"http:\/\/www.lgmd-info.org\/researcher-interview\/2018\/03\/04\/1737\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2018-03-05T00:32:55+00:00\",\"dateModified\":\"2018-03-05T00:32:55+00:00\",\"breadcrumb\":{\"@id\":\"http:\/\/www.lgmd-info.org\/researcher-interview\/2018\/03\/04\/1737\/#breadcrumb\"},\"inLanguage\":\"tr-TR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"http:\/\/www.lgmd-info.org\/researcher-interview\/2018\/03\/04\/1737\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr-TR\",\"@id\":\"http:\/\/www.lgmd-info.org\/researcher-interview\/2018\/03\/04\/1737\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"http:\/\/www.lgmd-info.org\/researcher-interview\/2018\/03\/04\/1737\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.lgmd-info.org\/de\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"LGMD RESEARCHER: Louise Rodino-Klapac, Ph.D\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.lgmd-info.org\/de\/#website\",\"url\":\"https:\/\/www.lgmd-info.org\/de\/\",\"name\":\"LGMD Awareness Foundation\",\"description\":\"Information Hub for the LGMD community\",\"publisher\":{\"@id\":\"https:\/\/www.lgmd-info.org\/de\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.lgmd-info.org\/de\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr-TR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.lgmd-info.org\/de\/#organization\",\"name\":\"LGMD Awareness Foundation, Inc.\",\"url\":\"https:\/\/www.lgmd-info.org\/de\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr-TR\",\"@id\":\"https:\/\/www.lgmd-info.org\/de\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/lgmd-info.org\/wp-content\/uploads\/2021\/02\/LGMD_Logo.png\",\"contentUrl\":\"https:\/\/lgmd-info.org\/wp-content\/uploads\/2021\/02\/LGMD_Logo.png\",\"width\":208,\"height\":61,\"caption\":\"LGMD Awareness Foundation, Inc.\"},\"image\":{\"@id\":\"https:\/\/www.lgmd-info.org\/de\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/LGMDawareness\/\",\"https:\/\/x.com\/LgmdAwareness\",\"https:\/\/www.instagram.com\/lgmdawareness\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.lgmd-info.org\/de\/#\/schema\/person\/007755074875959ad5503c1c969678c7\",\"name\":\"dooley\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr-TR\",\"@id\":\"https:\/\/www.lgmd-info.org\/de\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/c87b3b784fd4c1975884b6c3eab282b5?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/c87b3b784fd4c1975884b6c3eab282b5?s=96&d=mm&r=g\",\"caption\":\"dooley\"},\"sameAs\":[\"https:\/\/live-lgmd-2021.pantheonsite.io\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"LGMD RESEARCHER: Louise Rodino-Klapac, Ph.D - LGMD Awareness Foundation","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"http:\/\/www.lgmd-info.org\/tr\/researcher-interview\/2018\/03\/04\/1737\/","og_locale":"tr_TR","og_type":"article","og_title":"LGMD RESEARCHER: Louise Rodino-Klapac, Ph.D - LGMD Awareness Foundation","og_description":"LGMD &#8220;Spotlight Interview on Research\u201d LGMD Researcher: Louise Rodino-Klapac, Ph.D [&hellip;]","og_url":"http:\/\/www.lgmd-info.org\/tr\/researcher-interview\/2018\/03\/04\/1737\/","og_site_name":"LGMD Awareness Foundation","article_publisher":"https:\/\/www.facebook.com\/LGMDawareness\/","article_published_time":"2018-03-05T00:32:55+00:00","og_image":[{"width":1200,"height":630,"url":"https:\/\/www.lgmd-info.org\/wp-content\/uploads\/2021\/06\/LGMD-Logo_1200X630.png","type":"image\/png"}],"author":"dooley","twitter_card":"summary_large_image","twitter_creator":"@LgmdAwareness","twitter_site":"@LgmdAwareness","twitter_misc":{"Written by":"dooley","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"http:\/\/www.lgmd-info.org\/researcher-interview\/2018\/03\/04\/1737\/#article","isPartOf":{"@id":"http:\/\/www.lgmd-info.org\/researcher-interview\/2018\/03\/04\/1737\/"},"author":{"name":"dooley","@id":"https:\/\/www.lgmd-info.org\/de\/#\/schema\/person\/007755074875959ad5503c1c969678c7"},"headline":"LGMD RESEARCHER: Louise Rodino-Klapac, Ph.D","datePublished":"2018-03-05T00:32:55+00:00","dateModified":"2018-03-05T00:32:55+00:00","mainEntityOfPage":{"@id":"http:\/\/www.lgmd-info.org\/researcher-interview\/2018\/03\/04\/1737\/"},"wordCount":444,"publisher":{"@id":"https:\/\/www.lgmd-info.org\/de\/#organization"},"image":{"@id":"http:\/\/www.lgmd-info.org\/researcher-interview\/2018\/03\/04\/1737\/#primaryimage"},"thumbnailUrl":"","articleSection":["LGMD Researcher - Interviews","RESEARCHER"],"inLanguage":"tr-TR"},{"@type":"WebPage","@id":"http:\/\/www.lgmd-info.org\/researcher-interview\/2018\/03\/04\/1737\/","url":"http:\/\/www.lgmd-info.org\/researcher-interview\/2018\/03\/04\/1737\/","name":"LGMD RESEARCHER: Louise Rodino-Klapac, Ph.D - LGMD Awareness Foundation","isPartOf":{"@id":"https:\/\/www.lgmd-info.org\/de\/#website"},"primaryImageOfPage":{"@id":"http:\/\/www.lgmd-info.org\/researcher-interview\/2018\/03\/04\/1737\/#primaryimage"},"image":{"@id":"http:\/\/www.lgmd-info.org\/researcher-interview\/2018\/03\/04\/1737\/#primaryimage"},"thumbnailUrl":"","datePublished":"2018-03-05T00:32:55+00:00","dateModified":"2018-03-05T00:32:55+00:00","breadcrumb":{"@id":"http:\/\/www.lgmd-info.org\/researcher-interview\/2018\/03\/04\/1737\/#breadcrumb"},"inLanguage":"tr-TR","potentialAction":[{"@type":"ReadAction","target":["http:\/\/www.lgmd-info.org\/researcher-interview\/2018\/03\/04\/1737\/"]}]},{"@type":"ImageObject","inLanguage":"tr-TR","@id":"http:\/\/www.lgmd-info.org\/researcher-interview\/2018\/03\/04\/1737\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"http:\/\/www.lgmd-info.org\/researcher-interview\/2018\/03\/04\/1737\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.lgmd-info.org\/de\/"},{"@type":"ListItem","position":2,"name":"LGMD RESEARCHER: Louise Rodino-Klapac, Ph.D"}]},{"@type":"WebSite","@id":"https:\/\/www.lgmd-info.org\/de\/#website","url":"https:\/\/www.lgmd-info.org\/de\/","name":"LGMD Awareness Foundation","description":"Information Hub for the LGMD community","publisher":{"@id":"https:\/\/www.lgmd-info.org\/de\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.lgmd-info.org\/de\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr-TR"},{"@type":"Organization","@id":"https:\/\/www.lgmd-info.org\/de\/#organization","name":"LGMD Awareness Foundation, Inc.","url":"https:\/\/www.lgmd-info.org\/de\/","logo":{"@type":"ImageObject","inLanguage":"tr-TR","@id":"https:\/\/www.lgmd-info.org\/de\/#\/schema\/logo\/image\/","url":"https:\/\/lgmd-info.org\/wp-content\/uploads\/2021\/02\/LGMD_Logo.png","contentUrl":"https:\/\/lgmd-info.org\/wp-content\/uploads\/2021\/02\/LGMD_Logo.png","width":208,"height":61,"caption":"LGMD Awareness Foundation, Inc."},"image":{"@id":"https:\/\/www.lgmd-info.org\/de\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/LGMDawareness\/","https:\/\/x.com\/LgmdAwareness","https:\/\/www.instagram.com\/lgmdawareness\/"]},{"@type":"Person","@id":"https:\/\/www.lgmd-info.org\/de\/#\/schema\/person\/007755074875959ad5503c1c969678c7","name":"dooley","image":{"@type":"ImageObject","inLanguage":"tr-TR","@id":"https:\/\/www.lgmd-info.org\/de\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/c87b3b784fd4c1975884b6c3eab282b5?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/c87b3b784fd4c1975884b6c3eab282b5?s=96&d=mm&r=g","caption":"dooley"},"sameAs":["https:\/\/live-lgmd-2021.pantheonsite.io"]}]}},"_links":{"self":[{"href":"https:\/\/www.lgmd-info.org\/tr\/wp-json\/wp\/v2\/posts\/1737","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.lgmd-info.org\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.lgmd-info.org\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.lgmd-info.org\/tr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.lgmd-info.org\/tr\/wp-json\/wp\/v2\/comments?post=1737"}],"version-history":[{"count":0,"href":"https:\/\/www.lgmd-info.org\/tr\/wp-json\/wp\/v2\/posts\/1737\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.lgmd-info.org\/tr\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/www.lgmd-info.org\/tr\/wp-json\/wp\/v2\/media?parent=1737"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.lgmd-info.org\/tr\/wp-json\/wp\/v2\/categories?post=1737"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.lgmd-info.org\/tr\/wp-json\/wp\/v2\/tags?post=1737"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}